Netarsudil Dimesylate

Netarsudil Dimesylate Uses, Dosage, Side Effects, Food Interaction and all others data.

Table Of contents

• Netarsudil Dimesylate
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Netarsudil Dimesylate
Generic	Netarsudil Dimesylate
Type
Therapeutic Class	Drugs for miotics and glaucoma
Manufacturer
Available Country	Bangladesh
Last Updated:	September 24, 2024 at 5:38 am

Uses

Netarsudil ophthalmic solution is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

Dosage

Netarsudil Dimesylate dosage

The recommended dosage is one drop in the affected eye(s) once daily in the evening.

Side Effects

The most common ocular adverse reaction observed in controlled clinical studies with Netarsudil was conjunctival hyperemia, corneal verticillata, instillation site pain, corneal staining and blurred vision.

Precaution

For ophthalmic use only. To avoid possible contamination of the drops, do not touch the dropper tip or to any surface. Netarsudil can be used with other topical eye drug products, but they should be administered at least 5 minutes apart from each other. Contact lenses should be removed prior to instillation of Netarsudil and may be reinserted 15 minutes following its administration.

Interaction

This eye drops is contraindicated in patients who are hypersensitive to any component of this preparation.

Pregnancy & Breastfeeding use

Pregnancy: There are no adequate and well-controlled studies of Netarsudil ophthalmic solution in pregnant women to inform any drug-associated risk. However, systemic exposure to Netarsudil from ocular administration is low.Lactation: There are no data on the presence of Netarsudil in human milk, the effects on the breastfed infant, or the effects on milk production.Pediatric Use: Safety and effectiveness in pediatric patients below the age of 18 years have not been established.Use in elderly patients: No overall differences in safety and effectiveness have been observed between elderly and other adult patients.

Storage Condition

Store at 2°-8°C in a dry place, protect from light until opened. After opening the product may be kept at 2°-25°C for upto 6 weeks. Keep out of the reach of children.

Innovators Monograph

You find simplified version here Netarsudil Dimesylate